Scientific Sessions 2013 Preliminary Program - (Page 4)

PROGRAM SESSIONS* Acute and Chronic Complications Symposia • Small Fiber Dysfunction in the Natural History of Diabetic Neuropathies in Type 1 and Type 2 Diabetes— From the Bench to the Bedside • New Insights into Treatment of Diabetic Retinopathy and other Complications • Novel Insights into Diabetic Cardiomyopathy • Inflammation, Cardiovascular Disease, and Diabetes • Managing the Less Common Lipid Disorders • The Kidney’s Unholy Triad—Obesity, Hypertension, and Hyperglycemia • So Your Patient has Diabetic Kidney Disease—Now What? • Joint ADA/ASN Symposium—From Mice to Men and Back in Diabetic Kidney Disease • Osteomyelitis in the Diabetic Foot • Oh, My Aching Feet—Painful Diabetic Neuropathy of the Feet • Hypoglycemia in Clinical Practice • Defective Hypoglycemia Counterregulation in Diabetes Mellitus—Mechanisms, Prevention, and Reversal Clinical Diabetes/Therapeutics Current Issues • Quality Care Measures Can Unfavorably Impact Individual Care • Persistent Microalbuminuria as an Adequate Indication for Renin-Angiotensin-Aldosterone System (RAAS) Blocking Therapies • In a Patient who is Failing Oral Anti-Diabetic Agent Therapy, the Next Step is to? • Should Sulfonylureas Remain an Acceptable First-Line Add-On Therapy to Metformin? Symposia • The Future is Now—Changing Health Care Delivery Models • Maximizing Cost Effectiveness of Diabetes Prevention and Treatment—Practical Strategies • Continuous Glucose Monitoring (CGM) in the Management of Diabetes in Pregnancy • Update on Complications in Pregnancy in Women with Pre-Existing Diabetes • Applying Basic Science Technologies to Advance the Study of Maternal-Infant Outcomes in Obese and Diabetic Women • New Insulin Preparations for the Management of Diabetes • The Effect of Low Testosterone on Glycemic Control and Health in Diabetes and Obesity • Non-Glycemic Effects of Incretin-Based Therapy— Glucagon-Like Peptide-1 (GLP-1) and Dipeptidyl Peptidase-4 (DPP-4) • Diabetes in Older Adults • New Therapeutic Targets in Type 2 Diabetes Mellitus • Current State of Insulin Pump Therapy • Obesity Management for the Practicing Clinician • Non-Prescription Therapies for Diabetes Mellitus • Diabetes and the Bones • Pharmacologic Management of Obesity • In Utero and Beyond—Insulin Resistance, Puberty, and Pregnancy in Pediatric Diabetes • Closing the Communication Loop—Technology Update in Pediatric Diabetes • Moving Toward a Cure in Type 1 Diabetes • Joint ADA/AACC Symposium—Newer Biomarkers in Diabetes—Do They Add Value? • ADA Diabetes Care Symposium • China Medical Tribune Symposium Behavioral Medicine, Clinical Nutrition, Education, and Exercise Current Issues • Dietary Treatment of Obesity—Are all Calories Alike? Symposia • Intensifying Therapy using Technology and Teams • A Brave New World—Self-Management Support in the Community • Education Recharged—Diabetes and Technology • Diabetes Education—What Matters? • The Spectrum of Gluten-Related Disorders—A Dual Challenge in Diabetes • Dietary Sweeteners—Research, Recommendations, and the Real World • Mealtime Insulin Dosing—It’s More than Counting Carbohydrates • New Frontiers in Weight Management • Exercise as Adjunct Therapy for Insulin Sensitivity and Diabetes • Exercise and Lipid Metabolism • Behavioral Interventions for Diabetes—Evidence from Recent Intervention Studies • Sleep—A Novel Behavioral Target in Diabetes? • What Influences Patients’ Risk Perception and DecisionMaking for Diabetes Prevention and Control? 4 • ADA Education Recognition Program Symposium • National Diabetes Education Program Symposium *Session titles are subject to change. 

Table of Contents for the Digital Edition of Scientific Sessions 2013 Preliminary Program

Scientific Sessions 2013 Preliminary Program

https://www.nxtbookmedia.com